Enhanced recovery after surgery (ERAS) pathways have been shown to improve pancreatic surgery outcomes, though feasibility in a community hospital remain unclear. We hypothesized that an ERAS protocol would reduce hospital length of stay (LOS) without increased morbidity.
Methods
An ERAS pathway was initiated for patients undergoing pancreatic surgery at a community cancer center and compared to a historical cohort. The primary outcome was hospital LOS. Secondary outcomes included 30-day readmission rates, comprehensive complication index (CCI®), textbook outcomes (TO), and mortality.
Results
A total of 144 patients were included, with 63 patients in the ERAS group and 81 in the control group. The mean LOS decreased significantly in the ERAS group (6.85 [± 4.8]) vs 9.96 [±6.8] days, P = .001), without an increase in 30-day admission rates or CCI.
Conclusions
Implementation of an ERAS protocol in a community setting reduced LOS without a corresponding increase in readmission rates or morbidity.
SheetzKHDimickJBNathanH. Centralization of high-risk cancer surgery within existing hospital systems. J Clin Oncol. 2019;37:3234-3242.
2.
SabesanAGoughBLAndersonCet al., High volume pancreaticoduodenectomy performed at an academic community cancer center. Am J Surg. 2019;218:349-354.
3.
SchmidtCMTurriniOParikhP, et al.Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 2010;145:634-640.
StitzenbergKBSigurdsonEREglestonBL, et al.Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27:4671-4678.
6.
ChouJSomnayVWoodwykA, et al.The volume-outcome relationship and traveling for hepatobiliary and pancreatic surgery: a quantitative analysis of patient perspectives. Cureus. 2020;12(10):e11023. doi:10.7759/cureus.11023
7.
CusworthBMKrasnickBANyweningTM, et al.Whipple-specific complications result in prolonged length of stay not accounted for in ACS-NSQIP surgical risk calculator. HPB. 2017;19:147-153.
8.
LjungqvistOScottMFearonKC. Enhanced recovery after surgery a review. JAMA Surgery. 2017;152:292-298.
9.
LavuHMcCallNSWinterJM, et al.Enhancing patient outcomes while containing costs after complex abdominal operation: a randomized controlled trial of the whipple accelerated recovery pathway. J Am Coll Surg. 2019;228:415.
10.
MahendranRTewariMKumarVDShuklaHS, et al.Enhanced recovery after surgery protocol enhances early postoperative recovery after pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int. 2019;18:188-193.
11.
BragaMPecorelliNAriottiR, et al.Enhanced recovery after surgery pathway in patients undergoing pancreaticoduodenectomy. World J Surg. 2014;38:2960-2966.
12.
O’MahoneyPRAYeoHLSedrakyanA, et al.Centralization of pancreatoduodenectomy a decade later: impact of the volume-outcome relationship. Surgery. 2016;159:1528-1538.
13.
GeltzeilerCBRotramelAWilsonC, et al.Prospective study of colorectal enhanced recovery after surgery in a community hospital. JAMA Surg. 2014;149:955-961.
14.
LjungqvistOScottMFearonKC. Enhanced recovery after surgery a review. JAMA Surg. 2017;152:292-298.
15.
HamadAPwalikTEjazA. Guide to enhanced recovery for cancer patients undergoing surgery: pancreaticoduodenectomy. Ann Surg Oncol. 2021;28:6965-6969. doi:10.1245/S10434-021-09717-1
16.
KrammeKSarrafPShebrainSMuneneG. Safety and efficacy of prophylactic enoxaparin adjusted by anti-factor xa peak levels in pancreatic surgery. Am Surg. 2021;230:31348211023438. doi: 10.1177/00031348211023438
17.
BassiCMarchegianiGDervenisC, et al.The 2016 update of the international study group (isgps) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584-591. doi:10.1016/j.surg.2016.11.014
LavuHMcCallNSWinterJM, et al.Enhancing patient outcomes while containing costs after complex abdominal operation: a randomized controlled trial of the whipple accelerated recovery pathway. J Am Coll Surg. 2019;228:415.
20.
GeltzeilerCBRotramelAWilsonC, et al.Prospective study of colorectal enhanced recovery after surgery in a community hospital. JAMA Surg. 2014;149:955-961.
21.
PartelliACrippaSCastagniR, et al.Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patients. HPB. 2016;18:153-158.
22.
TakagiKYoshidaRYagiT, et al.Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. Clin Nutr. 2019;38:174-181.
23.
RoulinDMelloulEWellgB, et al.Feasibility of an enhanced recovery protocol for elective pancreatoduodenectomy: a multicenter international cohort study. World J Surg. 2020;44:2761-2769.
24.
ZaydfudimVM. Enhanced recovery in patients selected for pancreatoduodenectomy: standardization of care improves patient outcomes. World J Surg. 2020;44:2085-2086.
25.
Van RoesselSMackayTMvan DierenS, et al.Textbook outcome: nationwide analysis of a novel quality measure in pancreatic surgery. Ann Surg. 2020;271:155-162. doi:10.1097/SLA.0000000000003451
26.
AquinaCTHamadABecerraAZ, et al.Is textbook oncologic outcome a valid hospital-quality metric after high-risk surgical oncology procedures?Ann Surg Oncol. 2021;28:8028-8045. doi:10.1245/s10434-021-10478-0
27.
MerathKChenQBaganteF, et al.Textbook outcomes among medicare patients undergoing hepatopancreatic surgery. Ann Surg. 2020;271:1116-1123. doi:10.1097/SLA.0000000000003105
28.
NicholasEvan RoesselSde BurletK, et al.Using textbook outcomes to benchmark practice in pancreatic surgery. ANZ J Surg. 2021;91:361-366. doi:10.1111/ans.16555
29.
KimSHHwangHKLeeWJKangCM, et al.Comprehensive complication index or Clavien–Dindo classification: which is better for evaluating the severity of postoperative complications following pancreatectomy?World J Surg. 2021;45:849-856. doi:10.1007/s00268-020-05859-7
30.
VeličkovićJFengCPalibrkI, et al.The assessment of complications after major abdominal surgery: a comparison of two scales. J Surg Res. 2020;247:397-405. doi:10.1016/j.jss.2019.10.003
